CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- 4/A Exercise or conversion CFO acquired 4,000 shares (option exercise)
- 4/A Open-market sale Director sold 1,800 shares at $35.43 ($63,774)
- 4 Open-market sale Director sold 4,085 shares at an average $1,580.95 ($6,458,190)
- 4 Open-market sale CEO sold 4,070 shares at an average $35.43 ($144,180)
- 4 Open-market sale CFO sold 4,000 shares at an average $35.40 ($141,612)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 3,000 shares at $32.11 ($96,342)
- 4 Open-market sale Director sold 3,000 shares at $35.74 ($107,219)
- 4 Open-market sale Director sold 3,000 shares at $30.29 ($90,864)
- 4 Open-market sale Director sold 3,000 shares at $37.99 ($113,956)
- 4 Open-market sale Director sold 3,000 shares at $34.74 ($104,207)
- 4 Exercise or conversion Director acquired 22,000 shares (option exercise)
- 4 Exercise or conversion CEO acquired 50,008 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 2,189 shares (to pay taxes)
Page 7 of 10 · 200 filings